Cargando…
Using Microdosing to Induct Patients Into a Long-Acting Injectable Buprenorphine Depot Medication in Low Threshold Community Settings: A Case Study
Healthcare innovation has never been more important as it is now when the world is facing up to the unprecedented challenges brought by the COVID-19 pandemic. Within addictions services in Scotland, the priority has been to tackle our rising drug related death rate by maintaining and improving acces...
Autores principales: | Tay Wee Teck, Joseph, Baldacchino, Alexander, Gibson, Lauren, Lafferty, Con |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021866/ https://www.ncbi.nlm.nih.gov/pubmed/33833682 http://dx.doi.org/10.3389/fphar.2021.631784 |
Ejemplares similares
-
Outpatient Microdose Induction with Transdermal Buprenorphine: A Case Series
por: Menard, Shannon, et al.
Publicado: (2022) -
Implementing buprenorphine prolonged-release injection using a health at the margins approach for transactional sex-workers
por: Gittins, Rosalind, et al.
Publicado: (2023) -
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis
por: K. K., Adams, et al.
Publicado: (2022) -
Buprenorphine Microdosing Cross Tapers: A Time for Change
por: Raheemullah, Amer, et al.
Publicado: (2022) -
Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese method
por: Hämmig, Robert, et al.
Publicado: (2016)